Author | Ghassan K. Abou-Alfa, MD | OncLive

Author | Ghassan K. Abou-Alfa, MD

Articles

Dr. Abou-Alfa on Remaining Questions With Infigratinib in FGFR2+ Cholangiocarcinoma

July 16, 2020

Ghassan K. Abou-Alfa, MD, discusses the questions that remain with infigratinib in advanced cholangiocarcinoma with FGFR2 gene fusions/translocations.

Dr. Abou-Alfa on Sequencing Challenges in Metastatic HCC

April 11, 2020

Ghassan K. Abou-Alfa, MD, discusses sequencing challenges in metastatic hepatocellular carcinoma.

Dr. Abou-Alfa on Optimizing Treatment Selection in HCC

February 29, 2020

Ghassan K. Abou-Alfa, MD, discusses ways to optimize treatment selection for patients with hepatocellular carcinoma.

Dr. Abou-Alfa on Progress Made in Hepatocellular Carcinoma

February 11, 2020

Ghassan K. Abou-Alfa, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the progress that has been made in the treatment of patients with hepatocellular carcinoma (HCC).

x